CCM
TEVA icon

Convector Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Convector Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-58,000
Closed -$3.1M – 34
2016
Q1 		$3.1M Sell
58,000
-29,740
-34% -$1.74M 3.14% 12
2015
Q4 		$5.76M Buy
+87,740
New +$5.42M 5.42% 6

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Convector Capital Management's TEVA Position: Q2 2016 in Review

Convector Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2016, closing a stake of 58,000 shares — an estimated $3.1M sold.

Convector Capital Management first reported a position in TEVA in Q4 2015 and held it in 2 quarters. The position peaked at $5.76M in Q4 2015. 812 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

  • Convector Capital Management reported no remaining Teva Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Convector Capital Management sold 58,000 Teva Pharmaceuticals shares in Q2 2016, an estimated $3.1M.
  • Convector Capital Management first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 2 quarters.
  • Convector Capital Management's Teva Pharmaceuticals position peaked at $5.76M in Q4 2015.
  • 812 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on Convector Capital Management's 13F filing for Q2 2016, filed 4 Aug 2016.